V. A. Tell and . Hilgeroth, Recent developments of protein kinase inhibitors as potential AD therapeutics, Frontiers in Cellular Neuroscience, vol.7, pp.1-8, 2013.
DOI : 10.3389/fncel.2013.00189

Z. L. Chen, V. Haegeli, H. Yu, S. Strickland, G. Paglini et al., Cortical deficiency of laminin gamma1 impairs the AKT/GSK-3beta signaling pathway and leads to defects in neurite outgrowth and neuronal migration binding by CDK inhibitors, Dev. Biol. Eur J Biochem. J. Med, vol.327, issue.268, pp.158-168, 2001.

R. S. Jope, C. J. Yuskaitis, and E. Beurel, Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics, Neurochemical Research, vol.13, issue.Suppl. 2, pp.671-679, 2005.
DOI : 10.1007/s11064-006-9128-5
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1970866

J. Park and K. C. Chung, New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome, Experimental Neurobiology, vol.22, issue.4, pp.244-248, 2013.
DOI : 10.5607/en.2013.22.4.244

U. Becker, F. J. Soppa, and . Tejedor, DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies, CNS & Neurological Disorders - Drug Targets, vol.13, issue.1, pp.26-33, 2014.
DOI : 10.2174/18715273113126660186

J. R. Sundaram, C. P. Poore, N. H. Sulaimee, T. Pareek, A. B. Asad et al., Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo GSK-3 inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury, J. Neurosci. Biochem. Biophys. Res. Commun, vol.33, pp.334-343, 2011.

M. Hamada, A. Prochazkova, S. Terse, T. Takahashi, A. B. Ohshima et al., Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPAR agonist improves neuronal loss and early lethality, J. Neuroinflammation, vol.28, p.11, 2014.

J. Jayapalan and . Natarajan, The role of CDK5 and GSK3? kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer's disease, Bioinformation, vol.27, pp.1023-1030, 2013.

G. Li, T. Liu, X. Kong, L. Wang, and X. Jin, Hippocampal Glycogen Synthase Kinase 3?? is Critical for the Antidepressant Effect of Cyclin-Dependent Kinase 5 Inhibitor in Rats, Journal of Molecular Neuroscience, vol.15, issue.Suppl 5
DOI : 10.1007/s12031-014-0254-2

J. Miranda-barrientos, E. Nieto-mendoza, and E. Hernández-echeagaray, The Cdk5 Inhibitor Roscovitine Increases LTP Induction in Corticostriatal Synapses, ASN Neuro, vol.30, issue.2
DOI : 10.1016/j.neuropharm.2010.01.008

;. H. Nehmé, R. Nehmé, P. Lafite, S. Routier, . Ph et al., Human protein kinase inhibitor screening by capillary electrophoresis using transverse diffusion of laminar flow profiles for reactant mixing, Journal of Chromatography A, vol.1314, pp.1314-298, 2013.
DOI : 10.1016/j.chroma.2013.08.046

E. W. Kuehn and G. , Prime time for polycystic kidney disease: does one shot of roscovitine bring the cure?, Nephrology Dialysis Transplantation, vol.22, issue.8, pp.2133-2138, 2007.
DOI : 10.1093/ndt/gfm178

V. Cataldi and . Giacomo, Cyclin-dependent kinase modulators and cancer therapy, BioDrugs, vol.26, pp.377-91, 2012.

Y. Hajbi, C. Neagoie, B. Biannic, A. Chilloux, E. Vedrenne et al., Synthesis and biological activities of new furo[3,4-b]carbazoles: Potential topoisomerase II inhibitors, European Journal of Medicinal Chemistry, vol.45, issue.11, p.45, 2010.
DOI : 10.1016/j.ejmech.2010.09.003

K. Guillouzo, S. Lewiski, L. Bourg, S. Colliandre, J. Y. Routier et al., Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(phenyl) pyridine or pyrazine Vshaped molecules as kinase inhibitors and cytotoxic agents, Eur. J. Med. Chem, p.46, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00720615

L. Lozach, J. Y. Meijer, S. Mérour, and U. S. Routier, Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2- indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents, Bioorg. Med. M A N

C. Lansiaux, O. Bailly, L. Lozach, and . Meijer, Synthesis and biological evaluation of novel phenylcarbazoles as potential anticancer agents, J. Med. Chem, vol.49, pp.789-799, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00169630

. Caignard, Synthesis and biological evaluation of novel naphthocarbazoles as potential anticancer agents, J. Med. Chem, vol.48, pp.1401-1413, 2005.

Y. Akssira, G. Troin, S. Guillaumet, and . Routier, Novel tetrahydropyrido[1,2-a]isoindolone derivatives (valmerins): potent cyclin-dependent kinase/glycogen synthase kinase 3 inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts, J. Med
URL : https://hal.archives-ouvertes.fr/hal-00785213

M. Caballero, M. Garcia-valverde, R. Pedrosa, and M. Vicente, Elimination versus diastereoselective alkylation in homochiral 2-(??-ethoxy carbonyl) acetals, Tetrahedron: Asymmetry, vol.7, issue.1, pp.219-245, 1996.
DOI : 10.1016/0957-4166(95)00438-6

]. Alsarabi, J. L. Canet, B. R. Troin, S. H. Huck, and . Gellman, Short diastereoselective synthesis of cis-and trans-hexahydropyrido[2,1-a]isoindole derivatives, Tetrahedron Lett, vol.4512, issue.11 2, pp.9003-9006, 2004.

J. Greengard, E. Biernat, G. Mandelkow, L. Eisenbrand, and . Meijer, Indirubins inhibit glycogen synthase kinase -3 and CDK5 / p25, two kinases involved in abnormal tau phosphorylation in Alzheimer's disease -A property common to most CDK inhibitors ?, J. Biol. Chem, vol.27614, pp.251-260, 2001.

L. Costantini and . Meijer, Purification of GSK-3 by affinity chromatography on immobilised axin

P. Expr and . Purif, Molecular Operating Environment, Version 2013, Chemical Computing Group Inc, vol.201508, issue.16, pp.394-404, 2000.

T. Kohno, S. Sugio, and T. Matsuzaki, Structural insight into nucleotide recognition in tauprotein kinase I/glycogen synthase kinase 3?, Acta Cryst, pp.439-446, 2004.

L. Olsson, A. Aagaard, S. Geschwindner, Y. Xue, and M. Vasänge, Synthesis and structureactivity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclindependent kinase 5 (cdk5)/p25 inhibitors, Bioorg. Med. Chem. Lett, vol.22, pp.5919-5923, 2012.

P. Vilenchik, X. Wovkulich, and P. Zhang, Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors, Bioorg. Med. Chem. Lett, vol.220, issue.23, pp.6610-6615754, 0697.